{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:48:45Z","timestamp":1792763325763,"version":"4.5.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ymgme.2011.05.014","type":"journal-article","created":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T11:55:32Z","timestamp":1306324532000},"page":"48-60","source":"Crossref","is-referenced-by-count":284,"title":["Pyridoxine dependent epilepsy and antiquitin deficiency"],"prefix":"10.1016","volume":"104","author":[{"given":"Sylvia","family":"Stockler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Plecko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Sidney M.","family":"Gospe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Coulter-Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"van Karnebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadet","family":"Mercimek-Mahmutoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Scharer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Struijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Tein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Jakobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan L.K.","family":"Van Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1542\/peds.13.2.140","article-title":"Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine","volume":"13","author":"Hunt","year":"1954","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ymgme.2011.05.014_bb0010","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1017\/S0012162201000779","article-title":"Pyridoxine-dependent and pyridoxine-responsive seizures","volume":"43","author":"Baxter","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2011.05.014_bb0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-3476(99)70307-0","article-title":"Demographics and diagnosis of pyridoxine-dependent seizures","volume":"134","author":"Ebinger","year":"1999","journal-title":"J. Pediatr."},{"issue":"12","key":"10.1016\/j.ymgme.2011.05.014_bb0020","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/adc.2005.075069","article-title":"Epidemiology of pyridoxine dependent seizures in the Netherlands","volume":"90","author":"Been","year":"2005","journal-title":"Arch. Dis. Child."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/adc.81.5.431","article-title":"Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK","volume":"81","author":"Baxter","year":"1999","journal-title":"Arch. Dis. Child."},{"issue":"6","key":"10.1016\/j.ymgme.2011.05.014_bb0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpn.2005.08.005","article-title":"Prevalence of pyridoxine dependent seizures in south Indian children with early onset intractable epilepsy: a hospital based prospective study","volume":"9","author":"Ramachandran Nair","year":"2005","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1542\/peds.36.1.14","article-title":"Urinary vitamin B6 and 4-Pyridoxic acid in health and in vitamin B6 dependency","volume":"36","author":"Scriver","year":"1965","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0387-7604(00)00193-5","article-title":"CSF glutamate\/GABA concentrations in pyridoxine-dependent seizures: etiology of pyridoxine-dependent seizures and the mechanisms of pyridoxine action in seizure control","volume":"23","author":"Goto","year":"2001","journal-title":"Brain Dev."},{"issue":"8906","key":"10.1016\/j.ymgme.2011.05.014_bb0045","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(94)90236-4","article-title":"Reduced GABA synthesis in pyridoxine-dependent seizures","volume":"343","author":"Gospe","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2008-1071353","article-title":"Disturbance of GABA metabolism in pyridoxine-dependent seizures","volume":"23","author":"Kurlemann","year":"1992","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1542\/peds.94.3.318","article-title":"Glutamate in pyridoxine-dependent epilepsy: neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine","volume":"94","author":"Baumeister","year":"1994","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0060","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1086\/303087","article-title":"A gene for pyridoxine-dependent epilepsy maps to chromosome 5q31","volume":"67","author":"Cormier-Daire","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"55(2)","key":"10.1016\/j.ymgme.2011.05.014_bb0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1212\/WNL.55.2.309","article-title":"Glutamate decarboxylase is not genetically linked to pyridoxine-dependent seizures","volume":"25","author":"Battaglioli","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/1531-8249(200007)48:1<121::AID-ANA20>3.0.CO;2-V","article-title":"Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy","volume":"48","author":"Plecko","year":"2000","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm1366","article-title":"Mutations in antiquitin in individuals with pyridoxine-dependent seizures","volume":"12","author":"Mills","year":"2006","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0080","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.21568","article-title":"Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy","volume":"65","author":"Gallagher","year":"2009","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/humu.20433","article-title":"Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene","volume":"28","author":"Plecko","year":"2007","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ana.21206","article-title":"An intriguing \u201csilent\u201d mutation and a founder effect in antiquitin (ALDH7A1)","volume":"62","author":"Salomons","year":"2007","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0095","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1528-1167.2008.01816.x","article-title":"Prevalence of ALDH7A1 mutations in 18 North American pyridoxine-dependent seizure (PDS) patients","volume":"50","author":"Bennett","year":"2009","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ymgme.2007.02.010","article-title":"Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis","volume":"91","author":"Kanno","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0105","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10545-010-9187-2","article-title":"The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1","volume":"33","author":"Scharer","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Pt 7","key":"10.1016\/j.ymgme.2011.05.014_bb0110","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/brain\/awq143","article-title":"Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)","volume":"133","author":"Mills","year":"2010","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1469-8749.2007.00300.x","article-title":"Pyridoxine-dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regime","volume":"49","author":"Rankin","year":"2007","journal-title":"Dev. Med. Child Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2011.05.014_bb0120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pediatrneurol.2009.01.007","article-title":"Vitamins, not surgery: spinal fluid testing in hemispheric epilepsy","volume":"40","author":"Parikh","year":"2009","journal-title":"Pediatr. Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0029-1202833","article-title":"Pyridoxine-dependent epilepsy: normal outcome in a patient with late diagnosis after prolonged status epilepticus causing cortical blindness","volume":"39","author":"Kluger","year":"2008","journal-title":"Neuropediatrics"},{"issue":"12","key":"10.1016\/j.ymgme.2011.05.014_bb0130","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1177\/0883073808318543","article-title":"Pyridoxine-dependent seizures caused by alpha amino adipic semialdehyde dehydrogenase deficiency: the first polish case with confirmed biochemical and molecular pathology","volume":"23","author":"Kaczorowska","year":"2008","journal-title":"J. Child Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejpn.2010.03.011","article-title":"Novel mutations in pyridoxine-dependent epilepsy","volume":"15","author":"Millet","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0140","series-title":"GeneReviews [Internet]","article-title":"Pyridoxine-dependent seizures","author":"Gospe","year":"1993"},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0145","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/088307389601100519","article-title":"Pyridoxine-dependent epilepsy: the need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion","volume":"11","author":"Bass","year":"1996","journal-title":"J. Child Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1469-8749.1985.tb04551.x","article-title":"Pyridoxine for neonatal seizures: an unexpected danger","volume":"27","author":"Kroll","year":"1985","journal-title":"Dev. Med. Child Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2011.05.014_bb0155","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S0012162201000767","article-title":"Pyridoxine-dependent seizures responding to extremely low-dose pyridoxine","volume":"43","author":"Grillo","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0160","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2005-865727","article-title":"Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy","volume":"36","author":"Plecko","year":"2005","journal-title":"Neuropediatrics"},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1469-8749.1997.tb08206.x","article-title":"Pyridoxine dependency: an update","volume":"39","author":"Gordon","year":"1997","journal-title":"Dev. Med. Child Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0170","doi-asserted-by":"crossref","first-page":"F125","DOI":"10.1136\/fn.81.2.F125","article-title":"Pyridoxine dependent epilepsy: a suggestive electroclinical pattern","volume":"81","author":"Nabbout","year":"1999","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0887-8994(01)00407-6","article-title":"Pyridoxine-dependent seizures: findings from recent studies pose new questions","volume":"26","author":"Gospe","year":"2002","journal-title":"Pediatr. Neurol."},{"issue":"8","key":"10.1016\/j.ymgme.2011.05.014_bb0180","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1651-2227.2002.tb02866.x","article-title":"Amplitude-integrated encephalography in pyridoxine-dependent seizures and pyridoxine-responsive seizures","volume":"91","author":"Hellstrom-Westas","year":"2002","journal-title":"Acta Paediatr."},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0013-4694(91)90035-3","article-title":"Pyridoxine-dependent epilepsy: EEG investigations and long-term follow-up","volume":"78","author":"Mikati","year":"1991","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"issue":"7","key":"10.1016\/j.ymgme.2011.05.014_bb0190","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1469-8749.2010.03668.x","article-title":"Pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency: unique clinical symptoms and non-specific EEG characteristics","volume":"52","author":"Gospe","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1684\/epd.2009.0280","article-title":"Electroencephalographic changes in pyridoxine-dependant epilepsy: new observations","volume":"11","author":"Naasan","year":"2009","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0200","first-page":"291","article-title":"Pyridoxine dependent epileptic encephalopathy mimicking neonatal abstinence syndrome \u2014 a case report with video documentation","volume":"38","author":"Richter","year":"2008","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2011.05.014_bb0205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1469-8749.2010.03660.x","article-title":"Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency","volume":"52","author":"Schmitt","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0210","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF01958419","article-title":"Pyridoxine dependent seizures, clinical and therapeutic aspects","volume":"150","author":"Haenggeli","year":"1991","journal-title":"Eur. J. Paediatr."},{"issue":"Suppl1","key":"10.1016\/j.ymgme.2011.05.014_bb0215","first-page":"S158","article-title":"Atypical presentation of Antiquitin deficiency in a female with neonatal hypoglycemia, hyperlactic acidemia and intractable myoclonic epilepsy","volume":"33","author":"Mercimek-Mahmutoglu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0220","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/tropej\/48.5.303","article-title":"Pyridoxine-dependent seizures: long-term follow-up of two cases with clinical and MRI findings, and pyridoxine treatment","volume":"48","author":"Ulvi","year":"2002","journal-title":"J. Trop. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1212\/WNL.51.1.74","article-title":"Longitudinal MRI findings in pyridoxine-dependent seizures","volume":"51","author":"Gospe","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.28.1.47","article-title":"Vitamin B6-dependent seizures: pathology and chemical findings in brain","volume":"28","author":"Lott","year":"1978","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/088307389200700104","article-title":"Pyridoxine-dependent seizures: report of a case with atypical clinical features and abnormal MRI scans","volume":"7","author":"Tanaka","year":"1992","journal-title":"J. Child Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0240","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-2008-1073032","article-title":"Pyridoxine-dependent seizures associated with white matter abnormalities","volume":"25","author":"Jardim","year":"1994","journal-title":"Neuropediatrics"},{"issue":"9195","key":"10.1016\/j.ymgme.2011.05.014_bb0245","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(05)76825-2","article-title":"Neonatal seizures after pyridoxine use","volume":"354","author":"Baxter","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ymgme.2011.05.014_bb0250","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00431-008-0823-x","article-title":"Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry","volume":"168","author":"Basura","year":"2009","journal-title":"Eur. J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2011.05.014_bb0255","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/adc.58.6.415","article-title":"Pyridoxine dependent seizures\u2014a wider clinical spectrum","volume":"58","author":"Bankier","year":"1983","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.410170203","article-title":"Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants","volume":"17","author":"Goutieres","year":"1985","journal-title":"Ann. Neurol."},{"issue":"2 Pt 1","key":"10.1016\/j.ymgme.2011.05.014_bb0265","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1542\/peds.90.2.221","article-title":"Postneonatal vitamin B6-dependent epilepsy","volume":"90","author":"Coker","year":"1992","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.ymgme.2011.05.014_bb0270","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1469-8749.1996.tb15060.x","article-title":"Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient","volume":"38","author":"Baxter","year":"1996","journal-title":"Dev. Med. Child Neurol."},{"issue":"11","key":"10.1016\/j.ymgme.2011.05.014_bb0275","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1469-8749.2003.tb00889.x","article-title":"Pyridoxine-dependent seizures and cognition in adulthood","volume":"45","author":"Baynes","year":"2003","journal-title":"Dev. Med. Child Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0280","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00711760","article-title":"Folinic acid responsive seizures: a new syndrome?","volume":"18","author":"Hyland","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"issue":"8","key":"10.1016\/j.ymgme.2011.05.014_bb0285","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/088307389901400809","article-title":"Folinic acid-responsive neonatal seizures","volume":"14","author":"Torres","year":"1999","journal-title":"J. Child Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0290","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pediatrneurol.2005.08.019","article-title":"Folinic acid-responsive seizures initially responsive to pyridoxine","volume":"34","author":"Nicolai","year":"2006","journal-title":"Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0295","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ymgme.2009.05.002","article-title":"Mutation detection in DNA isolated from cerebrospinal fluid and urine: clinical utility and pitfalls of multiple displacement amplification","volume":"97","author":"Rosenberg","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0300","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/0264-6021:3440555","article-title":"Lysine degradation through the saccharopine pathway in mammals: involvement of both bifunctional and monofunctional lysine-degrading enzymes in mouse","volume":"344","author":"Papes","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0305","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Errors of lysine metabolism","author":"Cox","year":"2001"},{"key":"10.1016\/j.ymgme.2011.05.014_bb0310","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease. Chapter 95","article-title":"Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia","author":"Goodman","year":"2007"},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0315","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0167-4838(93)90108-4","article-title":"L-pipecolic acid oxidation in rat: subcellular localization and developmental study","volume":"1164","author":"Rao","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0320","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0305-0491(92)90435-T","article-title":"Developmental changes of l-lysine-ketoglutarate reductase in rat brain and liver","volume":"103","author":"Rao","year":"1992","journal-title":"Comp. Biochem. Physiol. B"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2011.05.014_bb0325","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0014-5793(00)02401-7","article-title":"The essential amino acid lysine acts as precursor of glutamate in the mammalian central nervous system","volume":"488","author":"Papes","year":"2001","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0330","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF00965321","article-title":"Pipecolic acid receptors in rat cerebral cortex","volume":"11","author":"Charles","year":"1986","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0335","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00964852","article-title":"Influence of pipecolic acid on the release and uptake of [3H]GABA from brain slices of mouse cerebral cortex","volume":"14","author":"Gutierrez","year":"1989","journal-title":"Neurochem. Res."},{"issue":"24","key":"10.1016\/j.ymgme.2011.05.014_bb0340","doi-asserted-by":"crossref","first-page":"18452","DOI":"10.1074\/jbc.M109.077925","article-title":"Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress","volume":"285","author":"Brocker","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.ymgme.2011.05.014_bb0345","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.febslet.2005.05.070","article-title":"Seabream antiquitin: molecular cloning, tissue distribution, subcellular localization and functional expression","volume":"579","author":"Tang","year":"2005","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0350","doi-asserted-by":"crossref","first-page":"e1000806","DOI":"10.1371\/journal.pgen.1000806","article-title":"Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis","volume":"6","author":"Guo","year":"2010","journal-title":"PLoS Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0355","first-page":"421","article-title":"Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping","volume":"9","author":"Vasiliou","year":"1999","journal-title":"Pharmacogenetics"},{"issue":"1\u20133","key":"10.1016\/j.ymgme.2011.05.014_bb0360","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(02)02553-X","article-title":"First purification of the antiquitin protein and demonstration of its enzymatic activity","volume":"516","author":"Tang","year":"2002","journal-title":"FEBS Lett."},{"issue":"20","key":"10.1016\/j.ymgme.2011.05.014_bb0365","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.febslet.2008.07.059","article-title":"The crystal structure of seabream antiquitin reveals the structural basis of its substrate specificity","volume":"582","author":"Tang","year":"2008","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0370","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/geno.1994.1279","article-title":"Homology between a human protein and a protein of the green garden pea","volume":"21","author":"Lee","year":"1994","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0375","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0167-4838(90)90241-7","article-title":"L-pipecolic acid metabolism in human liver: l-alpha-aminoadipate delta-semialdehyde oxidoreductase","volume":"1038","author":"Chang","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0380","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/pmic.200390024","article-title":"Progress in the definition of a reference human mitochondrial proteome","volume":"3","author":"Lescuyer","year":"2003","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0385","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jcb.22381","article-title":"Is antiquitin a mitochondrial enzyme?","volume":"109","author":"Wong","year":"2010","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0390","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1479-7364-2-2-138","article-title":"Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family","volume":"2","author":"Vasiliou","year":"2005","journal-title":"Hum. Genomics"},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0395","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1432-1033.1996.00779.x","article-title":"Computational method to predict mitochondrially imported proteins and their targeting sequences","volume":"241","author":"Claros","year":"1996","journal-title":"Eur. J. Biochem."},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0400","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1528-1167.2008.01741.x","article-title":"Two novel ALDH7A1 (antiquitin) splicing mutations associated with pyridoxine-dependent seizures","volume":"50","author":"Striano","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymgme.2011.05.014_bb0405","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N","article-title":"Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion","volume":"15","author":"den Dunnen","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0410","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-011-9279-7","article-title":"Pyridoxal 5\u2032-phosphate in cerebrospinal fluid; factors affecting concentration","author":"Footitt","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0415","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(84)90906-1","article-title":"Pyridoxal 5\u2032-phosphate concentration as marker for vitamin-B6-dependent seizures in the newborn","volume":"2","author":"Shin","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2011.05.014_bb0420","doi-asserted-by":"crossref","first-page":"15107","DOI":"10.1074\/jbc.M010860200","article-title":"Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid","volume":"276","author":"Farrant","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0425","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1592\/phco.26.10.1529","article-title":"Acute Isoniazid toxicity and the need for adequate pyridoxine supplies","volume":"26","author":"Morrow","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ymgme.2011.05.014_bb0430","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/sj.embor.embor914","article-title":"A genomic overview of pyridoxal-phosphate-dependant enzymes","volume":"4","author":"Percudani","year":"2003","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0435","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10409238909082552","article-title":"The family of glycogen phosphorylases: structure and function","volume":"24","author":"Newgard","year":"1989","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"1632(1\u20133)","key":"10.1016\/j.ymgme.2011.05.014_bb0440","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1388-1981(03)00059-3","article-title":"Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism","volume":"1","author":"Hanada","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0445","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbrc.2004.10.036","article-title":"Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5\u2032-phosphate binding domain exposed to the cytosol","volume":"325","author":"Ikeda","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0450","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10545-005-0071-4","article-title":"Pipecolic acid concentrations in brain tissue of nutritionally pyridoxine-deficient rats","volume":"28","author":"Plecko","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0455","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.febslet.2009.11.055","article-title":"Metabolism of lysine in alpha-aminoadipic semialdehyde dehydrogenase-deficient fibroblasts: evidence for an alternative pathway of pipecolic acid formation","volume":"584","author":"Struys","year":"2010","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0460","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ymgme.2007.04.016","article-title":"Alpha-aminoadipic semialdehyde is the biomarker for pyridoxine dependent epilepsy caused by alpha-aminoadipic semialdehyde dehydrogenase deficiency","volume":"91","author":"Struys","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.ymgme.2011.05.014_bb0465","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/adc.2006.103192","article-title":"Pyridoxine-dependent seizures in Dutch patients: diagnosis by elevated urinary alpha-aminoadipic semialdehyde levels","volume":"92","author":"Bok","year":"2007","journal-title":"Arch. Dis. Child."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0470","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneumeth.2009.07.019","article-title":"Simultaneous determination of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate and pipecolic acid by LC\u2013MS\/MS for pyridoxine-dependent seizures and folinic acid-responsive seizures","volume":"184","author":"Sadilkova","year":"2009","journal-title":"J. Neurosci. Methods"},{"issue":"Suppl1","key":"10.1016\/j.ymgme.2011.05.014_bb0475","first-page":"S536","article-title":"Urine screening strategies for 2-aminoadipic semialdehyde dehydrogenase deficiency","volume":"30","author":"Pitt","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0480","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ana.20610","article-title":"Pipecolic acid: a diagnostic marker in pyridoxine-dependent epilepsy","volume":"58","author":"Willemsen","year":"2005","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2011.05.014_bb0485","first-page":"8","article-title":"Molecular analysis of 54 patients with pyridoxine dependent epilepsy due to antiquitin deficiency","volume":"98","author":"Plecko","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0490","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ymgme.2004.04.010","article-title":"Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disorders","volume":"82","author":"Peduto","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0495","series-title":"Laboratory Guide to the Methods in Biochemical Genetics","first-page":"129","article-title":"Pipecolic acid","author":"Duran","year":"2008"},{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0500","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0009-8981(87)90283-X","article-title":"Stable isotope dilution analysis of pipecolic acid in cerebrospinal fluid, plasma, urine and amniotic fluid using electron capture negative ion mass fragmentography","volume":"168","author":"Kok","year":"1987","journal-title":"Clin. Chim. Acta"},{"issue":"Suppl 1","key":"10.1016\/j.ymgme.2011.05.014_bb0505","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00711428","article-title":"Pre- and postnatal diagnosis of peroxisomal disorders using stable-isotope dilution gas chromatography\u2013mass spectrometry","volume":"18","author":"Verhoeven","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"issue":"12","key":"10.1016\/j.ymgme.2011.05.014_bb0510","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1111\/j.1528-1167.2010.02747.x","article-title":"The EEG response to pyridoxine-IV neither identifies nor excludes pyridoxine-dependent epilepsy","volume":"51","author":"Bok","year":"2010","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0515","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1017\/S0317167100040506","article-title":"Pyridoxine dependent epilepsy with iatrogenic sensory neuronopathy","volume":"22","author":"McLachlan","year":"1995","journal-title":"Can. J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0520","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10545-006-0508-4","article-title":"Pyridoxal 5\u2032-phosphate may be curative in early-onset epileptic encephalopathy","volume":"30","author":"Hoffmann","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0525","doi-asserted-by":"crossref","first-page":"F151","DOI":"10.1136\/adc.2006.115162","article-title":"Pyridoxal phosphate-dependent neonatal epileptic encephalopathy","volume":"93","author":"Bagci","year":"2008","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0530","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/adc.2003.045963","article-title":"Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy","volume":"90","author":"Wang","year":"2005","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0535","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/01.wco.0000218230.81301.12","article-title":"Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment","volume":"19","author":"Gospe","year":"2006","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0540","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1471-4159.1981.tb02401.x","article-title":"Anticonvulsant activity of muscimol and g-aminobutyric acid against pyridoxal phosphate-induced epileptic seizures","volume":"36","author":"Kouyoumdjian","year":"1981","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0545","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00431-009-1020-2","article-title":"Antenatal treatment in two Dutch families with pyridoxine-dependent seizures","volume":"169","author":"Bok","year":"2010","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0550","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1090-3798(98)80007-X","article-title":"A paradoxical rise of neonatal seizures after treatment with vitamin B6","volume":"2","author":"Hammen","year":"1998","journal-title":"Eur. J. Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0555","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10545-005-0243-2","article-title":"B6-responsive disorders: a model of vitamin dependency","volume":"29","author":"Clayton","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0560","unstructured":"H. Hartmann, M. Fingerhut, C. Jakobs, B. Plecko, Status epilepticus in a newborn treated with pyridoxine due to a familial recurrence risk for antiquitin deficiency\u2013pyridoxine toxicity? Dev. Med. Child Neurol. in press."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0565","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10545-006-0451-4","article-title":"Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I)","volume":"30","author":"K\u00f6lker","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.ymgme.2011.05.014_bb0570","first-page":"S73","article-title":"Vitamin B6 dependent seizures","volume":"36","author":"Plecko","year":"2009","journal-title":"Can. J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0575","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3476(70)80047-6","article-title":"Familial hyperphosphatase with mental retardation, seizures, and neurologic deficits","volume":"77","author":"Mabry","year":"1970","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2011.05.014_bb0580","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejmg.2010.01.002","article-title":"Hyperphosphatasia with mental retardation, brachytelephalangy, and a distinct facial gestalt: delineation of a recognizable syndrome","volume":"53","author":"Horn","year":"2010","journal-title":"Eur. J. Med. Genet."},{"issue":"7","key":"10.1016\/j.ymgme.2011.05.014_bb0585","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ajmg.a.33438","article-title":"Hyperphosphatasia with seizures, neurologic deficit, and characteristic facial features: five new patients with Mabry syndrome","volume":"152A","author":"Thompson","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"issue":"10","key":"10.1016\/j.ymgme.2011.05.014_bb0590","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.653","article-title":"Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome","volume":"42","author":"Krawitz","year":"2010","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2011.05.014_bb0595","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1515\/DMDI.1982.4.4.289","article-title":"Drug-pyridoxal phosphate interactions","volume":"4","author":"Ebadi","year":"1982","journal-title":"Q. Rev. Drug Metab. Drug Interact."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0600","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1749-6632.1969.tb46386.x","article-title":"Mechanism of drug-induced vitamin B6 deficiency","volume":"166","author":"Levy","year":"1969","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0605","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1442-200X.2008.02712.x","article-title":"Very-late-onset pyridoxine-dependent seizures not linking to the known 5q31 locus","volume":"50","author":"Kabakus","year":"2008","journal-title":"Pediatr. Int."},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0610","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10048-005-0221-8","article-title":"Genetic heterogeneity for autosomal recessive pyridoxine-dependent seizures","volume":"6","author":"Bennett","year":"2005","journal-title":"Neurogenetics"},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0615","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0887-8994(97)00035-0","article-title":"Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children","volume":"17","author":"Jiao","year":"1997","journal-title":"Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2011.05.014_bb0620","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/088307389601100109","article-title":"Combination therapy of infantile spasms with high-dose pyridoxal phosphate and low-dose corticotropin","volume":"11","author":"Takuma","year":"1996","journal-title":"J. Child Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0625","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1111\/j.1440-1819.1995.tb02198.x","article-title":"Recurrence of seizures in childhood epilepsy after discontinuation of antiepileptic drugs","volume":"49","author":"Hirokawa","year":"1995","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.ymgme.2011.05.014_bb0630","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0887-8994(00)00185-5","article-title":"Long-term follow-up of vitamin B(6)-responsive West syndrome","volume":"23","author":"Ohtsuka","year":"2000","journal-title":"Pediatr. Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2011.05.014_bb0635","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1212\/WNL.48.5.1468","article-title":"Efficacy of pyridoxal phosphate in treating an adult with intractable status epilepticus","volume":"48","author":"Nakagawa","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2011.05.014_bb0640","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/ajcn\/1.3.200","article-title":"Pyridoxine deficiency in the human infant","volume":"1","author":"Synderman","year":"1953","journal-title":"J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2011.05.014_bb0645","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.1954.02940390029008","article-title":"Convulsions in young infants as a result of pyridoxine (Vitamin B6) deficiency","volume":"154","author":"Molony","year":"1954","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2011.05.014_bb0650","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jama.1954.02940390030009","article-title":"Convulsive seizures in infants with pyridoxine deficient diet","volume":"154","author":"Coursin","year":"1954","journal-title":"J. Am. Med. Assoc."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719211001661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719211001661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T03:33:40Z","timestamp":1712460820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719211001661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":130,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1096719211001661"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2011.05.014","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}